It's estimated 1 in 7 women suffer from the condition after giving birth.
The agency announced zuranolone, under the brand name Zurzuvae, had been approved as a once-daily pill to be taken for 14 days.
Women often turn to counseling for help managing postpartum depression. Previously, the only FDA-approved treatment forwas in the form of an IV injection, Zulresso, that could be administered only in certain health-care facilities. The pill, however, can be taken easily at home. The FDA warned that the drug’s side effects can include drowsiness, dizziness, fatigue, diarrhea, urinary tract infection and nasopharyngitis . The agency also warned that patients should not drive for at least 12 hours after taking the pill; Meltzer-Brody said the medication is best taken at night before sleep.
She said maternal depression is also affected by factors such as lower socio-economic status, education levels and exposure to trauma and gender-based violence, particularly among women of color.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
First-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Les mer »
First-ever pill for postpartum depression is up for FDA approval this weekThe Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
Les mer »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Les mer »
First Pill for Postpartum Depression Is Approved by FDAThe pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial.
Les mer »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Les mer »
FDA approves first-ever pill for postpartum depression in new mothersBiogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.
Les mer »